BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report) dropped 0.1% during mid-day trading on Tuesday . The company traded as low as $0.3901 and last traded at $0.4090. Approximately 650,071 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 62,169,492 shares. The stock had previously closed at $0.4096.
BioRestorative Therapies Price Performance
The firm’s fifty day moving average is $0.28 and its 200 day moving average is $0.57. The firm has a market capitalization of $670.61 million, a price-to-earnings ratio of -0.38 and a beta of 102.36.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc is a clinical‐stage regenerative medicine company focused on developing and commercializing advanced therapeutic platforms to promote tissue repair and healing. The company’s principal business activities are conducted through its wholly owned subsidiary, TissueForm, Inc, which holds the rights to a proprietary micro‐fiber scaffold technology designed to create a three‐dimensional matrix supporting cell migration, proliferation and new tissue formation. BioRestorative’s work is primarily targeted at chronic and non‐healing wounds, including diabetic foot ulcers and other complex soft‐tissue injuries.
The cornerstone of BioRestorative’s product pipeline is the TissueForm® line of scaffold materials.
Featured Stories
- Five stocks we like better than BioRestorative Therapies
- Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
- Apple’s Intel Deal Arrives at the Right Time for Its Stock
- Liquid Gold: The AI Cooling Retrofit Trade
- 3 Dividend Stocks Under $30 to Anchor Your Portfolio
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
